vs

Side-by-side financial comparison of Medalist Diversified REIT, Inc. (MDRR) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.

Medalist Diversified REIT, Inc. is the larger business by last-quarter revenue ($2.8M vs $2.2M, roughly 1.3× Instil Bio, Inc.). Medalist Diversified REIT, Inc. runs the higher net margin — -18.8% vs -365.3%, a 346.6% gap on every dollar of revenue. On growth, Medalist Diversified REIT, Inc. posted the faster year-over-year revenue change (11.8% vs -19.2%).

Medalist Diversified REIT, Inc. is a publicly traded real estate investment trust focused on owning, operating, and acquiring income-generating multi-family residential properties. Its portfolio is concentrated in high-growth US Southeast and Mid-Atlantic markets, targeting stable long-term returns for shareholders via rental income and property appreciation.

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

MDRR vs TIL — Head-to-Head

Bigger by revenue
MDRR
MDRR
1.3× larger
MDRR
$2.8M
$2.2M
TIL
Growing faster (revenue YoY)
MDRR
MDRR
+31.0% gap
MDRR
11.8%
-19.2%
TIL
Higher net margin
MDRR
MDRR
346.6% more per $
MDRR
-18.8%
-365.3%
TIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDRR
MDRR
TIL
TIL
Revenue
$2.8M
$2.2M
Net Profit
$-529.6K
$-8.2M
Gross Margin
Operating Margin
14.8%
-426.3%
Net Margin
-18.8%
-365.3%
Revenue YoY
11.8%
-19.2%
Net Profit YoY
-88.4%
31.1%
EPS (diluted)
$-0.49
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDRR
MDRR
TIL
TIL
Q4 25
$2.8M
$2.2M
Q3 25
$2.8M
$2.2M
Q2 25
$2.5M
$2.2M
Q1 25
$2.3M
$2.2M
Q4 24
$2.5M
$2.8M
Q3 24
$2.3M
$1.5M
Q2 24
$2.3M
$0
Q1 24
$2.6M
$0
Net Profit
MDRR
MDRR
TIL
TIL
Q4 25
$-529.6K
$-8.2M
Q3 25
$-395.9K
$-13.6M
Q2 25
$-456.4K
$-21.4M
Q1 25
$-1.0M
$-28.2M
Q4 24
$-281.2K
$-11.9M
Q3 24
$-527.0K
$-23.0M
Q2 24
$-521.7K
$-14.9M
Q1 24
$1.4M
$-24.3M
Operating Margin
MDRR
MDRR
TIL
TIL
Q4 25
14.8%
-426.3%
Q3 25
15.8%
-670.0%
Q2 25
9.8%
-1045.5%
Q1 25
-23.8%
-1363.2%
Q4 24
17.7%
-426.1%
Q3 24
13.0%
-1582.8%
Q2 24
9.4%
Q1 24
Net Margin
MDRR
MDRR
TIL
TIL
Q4 25
-18.8%
-365.3%
Q3 25
-14.2%
-606.0%
Q2 25
-18.5%
-954.2%
Q1 25
-43.4%
-1257.8%
Q4 24
-11.1%
-428.8%
Q3 24
-22.6%
-1541.9%
Q2 24
-22.7%
Q1 24
52.8%
EPS (diluted)
MDRR
MDRR
TIL
TIL
Q4 25
$-0.49
$-1.13
Q3 25
$-0.33
$-2.01
Q2 25
$-0.34
$-3.24
Q1 25
$-0.74
$-4.32
Q4 24
$-0.24
$-1.82
Q3 24
$-0.47
$-3.54
Q2 24
$-0.47
$-2.29
Q1 24
$1.21
$-3.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDRR
MDRR
TIL
TIL
Cash + ST InvestmentsLiquidity on hand
$2.6M
$6.6M
Total DebtLower is stronger
$51.4M
Stockholders' EquityBook value
$9.4M
$113.9M
Total Assets
$77.7M
$203.5M
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDRR
MDRR
TIL
TIL
Q4 25
$2.6M
$6.6M
Q3 25
$1.9M
$5.8M
Q2 25
$2.0M
$7.7M
Q1 25
$2.7M
$15.4M
Q4 24
$4.8M
$8.8M
Q3 24
$3.1M
$6.7M
Q2 24
$3.8M
$6.8M
Q1 24
$3.6M
$5.5M
Total Debt
MDRR
MDRR
TIL
TIL
Q4 25
$51.4M
Q3 25
$63.6M
Q2 25
$49.6M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MDRR
MDRR
TIL
TIL
Q4 25
$9.4M
$113.9M
Q3 25
$10.4M
$120.4M
Q2 25
$13.4M
$131.7M
Q1 25
$14.0M
$144.9M
Q4 24
$15.0M
$169.4M
Q3 24
$12.6M
$176.3M
Q2 24
$13.2M
$195.0M
Q1 24
$13.7M
$205.8M
Total Assets
MDRR
MDRR
TIL
TIL
Q4 25
$77.7M
$203.5M
Q3 25
$92.1M
$211.8M
Q2 25
$77.7M
$231.0M
Q1 25
$78.2M
$237.4M
Q4 24
$75.1M
$263.6M
Q3 24
$74.6M
$272.6M
Q2 24
$75.2M
$294.3M
Q1 24
$76.0M
$306.3M
Debt / Equity
MDRR
MDRR
TIL
TIL
Q4 25
5.45×
Q3 25
6.13×
Q2 25
3.70×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDRR
MDRR
TIL
TIL
Operating Cash FlowLast quarter
$1.5M
$-7.1M
Free Cash FlowOCF − Capex
$77.0K
FCF MarginFCF / Revenue
2.7%
Capex IntensityCapex / Revenue
51.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDRR
MDRR
TIL
TIL
Q4 25
$1.5M
$-7.1M
Q3 25
$1.6M
$-10.6M
Q2 25
$244.1K
$-14.8M
Q1 25
$460.0K
$-4.2M
Q4 24
$1.8M
$-10.6M
Q3 24
$139.9K
$-20.1M
Q2 24
$778.6K
$-10.6M
Q1 24
$492.4K
$-14.4M
Free Cash Flow
MDRR
MDRR
TIL
TIL
Q4 25
$77.0K
Q3 25
$1000.0K
Q2 25
$-181.5K
Q1 25
$322.4K
Q4 24
$893.7K
Q3 24
$-164.7K
Q2 24
$645.6K
Q1 24
$265.8K
FCF Margin
MDRR
MDRR
TIL
TIL
Q4 25
2.7%
Q3 25
35.9%
Q2 25
-7.4%
Q1 25
13.9%
Q4 24
35.4%
Q3 24
-7.0%
Q2 24
28.1%
Q1 24
10.3%
Capex Intensity
MDRR
MDRR
TIL
TIL
Q4 25
51.5%
Q3 25
20.4%
Q2 25
17.3%
Q1 25
5.9%
Q4 24
35.7%
0.0%
Q3 24
13.0%
0.0%
Q2 24
5.8%
Q1 24
8.8%
Cash Conversion
MDRR
MDRR
TIL
TIL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDRR
MDRR

Retail Center Properties$1.6M58%
Other$1.2M42%

TIL
TIL

Segment breakdown not available.

Related Comparisons